ХИМИОТЕРАПИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ У СОБАК
Abstract
Treatment sick of a cancer of a mammary gland represents one of most challenges of clinical oncology, that
first of all is connected with the heterogeneity of disease moderated by sensitivity of a tumour to chemotherapy
and a hormone of therapy, absence of absolute attributes of sensitivity and resistency to modern
antineoplastic preparations. Received by us the result testifies to advantage of application cyclophosphany
with 5-phtorurasylli in increase without recurrent and common survival rate in a combination with massive
immunity therapy.
first of all is connected with the heterogeneity of disease moderated by sensitivity of a tumour to chemotherapy
and a hormone of therapy, absence of absolute attributes of sensitivity and resistency to modern
antineoplastic preparations. Received by us the result testifies to advantage of application cyclophosphany
with 5-phtorurasylli in increase without recurrent and common survival rate in a combination with massive
immunity therapy.
About the Authors
Г. Терентюк
ФГОУ ВПО «Воронежский государственный аграрный университет»
Russian Federation
Russian Federation
В. Черванев
ФГОУ ВПО «Воронежский государственный аграрный университет»
Russian Federation
Russian Federation
References
1. Wallach J. Interpretation of diagnostic testes. Boston. 2004.
2. Sutherland E.W. Studies on the mechanism of hormone action.- Science, 2002, v.177, p. 401-405
3. Zimmerman H.J. Tests of hepatic function - In: Clinical diagnosis by laboratory methods. Philadelphia, London, Toronto 1999, o. 678-684
4. Жмаева Е.М. Прогнозирование ближайших и отдаленных результатов лечения больных раком молочной железы. Автореферат кандидата медицинских наук. М.,2002, 28 с.
5. Терентюк Г.С., Черванев В.А., Пальцев С.С. Не- оплазии молочных желез у собак. Воронеж: Истоки, 2007. 152 с.
Review
For citations:
, . Russian Journal of Veterinary Pathology. 2008;(1):76-79. (In Russ.)
Views:
48
Email this article 